Riociguat for the treatment of pulmonary hypertension in patients with end stage renal disease

被引:1
|
作者
Cangialosi, Peter [1 ]
Wojtaszek, Ewelina [2 ]
Omar, Alaa [3 ]
Gopalan, Radha [4 ]
Abel, Dileyni [1 ]
Tinuoye, Elizabeth [1 ]
Contreras, Johanna P. [5 ]
Love, Barry A. [6 ]
Trivieri, Maria Giovanna [7 ,8 ]
机构
[1] Mt Sinai Hosp, New York, NY USA
[2] JCMC RWJ Barnabas Hlth, Internal Med, Jersey City, NJ USA
[3] Mt Sinai Morningside, Dept Cardiol, New York, NY USA
[4] Univ Arizona, Banner Univ, Adv Heart Failure, Mech Circulatory Support & Transplant,Coll Med, Phoenix, AZ USA
[5] Mt Sinai Hosp, Mech Circulatory Support & Transplant, Adv Heart Failure, New York, IL USA
[6] Icahn Sch Med Mt Sinai, Dept Pediat Cardiol, New York, NY USA
[7] Mt Sinai Hosp, Mech Circulatory Support & Transplant, Pulm Hypertens Adv Heart Failure, New York, NY USA
[8] 1 Gustave Levy Pl,POB 1030, New York, NY 10029 USA
关键词
NITRIC-OXIDE;
D O I
10.1016/j.rmed.2023.107454
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [21] ROLE OF GROUP 5 PULMONARY HYPERTENSION IN END-STAGE RENAL DISEASE PATIENTS
    Akkanti, Bindu
    Kazzaz, Farah
    Rao, Adiswhar
    Agrawal, Akriti
    Patarroyo, Gabriel
    McKelvy, Brandy
    Kha Dinh
    Prada, Robiar Aguillon
    Patel, Bela
    CRITICAL CARE MEDICINE, 2024, 52
  • [22] Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis
    Van Buren, Peter Noel
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (12)
  • [23] Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis
    Peter Noel Van Buren
    Current Cardiology Reports, 2016, 18
  • [24] Hypertension in end-stage renal disease patients
    Zager, P
    Nikolic, J
    Raj, DSC
    Tzamaloukas, A
    Campbell, M
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (03): : 279 - 283
  • [25] PULMONARY VASCULAR RESISTANCE PREDICTS MORTALITY IN END-STAGE RENAL DISEASE PATIENTS WITH PULMONARY HYPERTENSION
    Wolfe, Jonathan
    Hickey, Gavin
    Althouse, Andrew
    Sharbaugh, Michael
    Pasupula, Deepak Kumar
    Kliner, Dustin
    Mathier, Michael
    Soman, Prem
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1909 - 1909
  • [26] Pulmonary vascular resistance determines mortality in end-stage renal disease patients with pulmonary hypertension
    Wolfe, Jonathan D.
    Hickey, Gavin W.
    Althouse, Andrew D.
    Sharbaugh, Michael S.
    Kliner, Dustin E.
    Mathier, Michael A.
    Wu, Christine M.
    Tevar, Amit D.
    Soman, Prem
    CLINICAL TRANSPLANTATION, 2018, 32 (06)
  • [27] Pulmonary hypertension in end-stage renal disease patients on dialysis and pre-dialysis patients
    Li, Yifu
    Zhang, Yan
    Wang, Jinjun
    Chen, Wenwei
    Cai, Yong
    Yang, Mei
    Li, Xiaolin
    CLINICAL AND INVESTIGATIVE MEDICINE, 2020, 43 (03): : E44 - E48
  • [28] Riociguat in the Treatment of Pulmonary Arterial Hypertension
    Jerjes-Sanchez, Carlos
    Glenn-Valdez, Hector
    Zayas, Nayeli
    Cueto-Robledo, Guillermo
    Bonola, Liliana
    Pech-Alonso, Baltazar
    Ramirez, Alicia
    Flores-Puente, Fernando
    Garcia-Aguilar, Humberto
    Espitia-Hernandez, Guadalupe
    Prisciliano Montes, Guillermo
    Pulido, Tomas
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (04) : 352 - 358
  • [29] Riociguat for the Treatment of Pulmonary Arterial Hypertension
    Ghofrani, Hossein-Ardeschir
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne M.
    Langleben, David
    Kilama, Michael Ochan
    Fritsch, Arno
    Neuser, Dieter
    Rubin, Lewis J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04): : 330 - 340
  • [30] RIOCIGUAT IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND SEVERE RENAL IMPAIRMENT
    Yarovoy, S.
    Danilov, N.
    Chazova, I.
    JOURNAL OF HYPERTENSION, 2019, 37 : E264 - E264